Affiliation:
1. Department of Social Pharmacy and Pharmacoepidemiology, Groningen University Institute for Drug Exploration, University of Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands
2. Department of Clinical Pharmacology and Hospital Pharmacy, General Hospital De Tjongerschans, Heerenveen, The Netherlands
Abstract
AbstractObjectivesTo measure the extent of pharmacotherapeutic coherence across sectors of Dutch health care from the hospitals' perspective, and to identify perceived markers of coherence and barriers to improvementMethodsTelephone interviews were carried out with hospital pharmacists (76), community pharmacists (5), and clinical pharmacologists (9) affiliated to pharmacies serving 120 Dutch general hospitals. Coherence between (a) hospital and general practice, (b) hospital and nursing home practice, (c) hospitals, and (d) hospital inpatient and outpatient practice was reported and assessed against a set of indicatorsResultsAlmost all hospitals (93 per cent) had formulary agreements or prescribing policies in place and 86 per cent of these had a printed hospital drug formulary (HDF). Over 50 per cent of hospitals reported that they had established coherence with nursing home practice and/or with other hospitals. Less than half of the hospitals had established coherence with general practice. Few hospitals reported activities to review outpatient prescribing and its implications for follow-on prescribing in primary care. Reported barriers to increasing coherence could be classed into three categories: economic, organisational and social. Suggestions to enhance coherence included influencing professionals' practice through training, and greater use of regional and national policies on prescribingConclusionTherapeutic coherence within Dutch health care is far from ideal. The discrepancy between the actual and desired extent of coherence arises from organisational and economic barriers. To date, activities in this area have relied on professional proactivity rather than a structured approach. To move forward, (dis)incentives should be created for health care providers and professionals across all sectors, including pharmacists and prescribers
Publisher
Oxford University Press (OUP)
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmaceutical Science,Pharmacy
Reference53 articles.
1. Economic aspects of drug therapy in hospitals: an issue for clinical pharmacologists;Harder;Int J Clin Pharmacol Ther,1994
2. Pharmacists as agents of change for rational drug therapy;Levens-Lipton;Int J Technol Ass Health Care,1995
3. Pharmacy involvement in formulary development: community pharmacists' views;Hughes;Int J Pharm Pract,1996
4. The pharmacist's contribution to medical audit: perceptions of doctors and pharmacists in the North West Thames Regional Health Authority;Harris;J Soc Adm Pharm,1993
5. The involvement of pharmacists in professional and clinical audit in the UK: a review and assessment of their potential role;Panton;J Eval Clin Pract,1996
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献